Q4

INDOCO REMEDIES LTD.

INDOCOFY2522 May 2025

Revenue-5.0%

Net Profit-45.6%

OPM-0.20%

P&L

Quarterly Consolidated

Revenue

-5.0%390.21

Expenditure

-1.3%437.75

Net Profit

-45.6%-41.34

NPM -10.54%-52.8%EPS ₹4.48+245.4%

vs Q3 FY25

Informational and educational content only. Not investment advice.